Funds and ETFs Bausch Health Companies Inc.

Equities

BHC

CA0717341071

Pharmaceuticals

Market Closed - Nyse 04:00:01 2024-04-25 pm EDT 5-day change 1st Jan Change
8.62 USD +0.70% Intraday chart for Bausch Health Companies Inc. +0.23% +7.48%
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
8.62 USD
Average target price
10.07 USD
Spread / Average Target
+16.84%
Consensus
  1. Stock Market
  2. Equities
  3. BHC Stock
  4. Funds and ETFs Bausch Health Companies Inc.